TreeWAS – Variant ID: rs55946907

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I42.0 Dilated cardiomyopathy	0.000	0.992	0.008
M85.89 Other specified disorders of bone density and structure (Site unspecified)	0.008	0.992	0.000
D25.1 Intramural leiomyoma of uterus	0.000	0.992	0.008
Y86 Sequelae of other accidents	0.000	0.992	0.008
I42 Cardiomyopathy	0.000	0.992	0.008
I42.9 Cardiomyopathy, unspecified	0.000	0.992	0.008
N93.0 Postcoital and contact bleeding	0.000	0.993	0.007
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.993	0.007
I42.2 Other hypertrophic cardiomyopathy	0.000	0.993	0.007
I42.6 Alcoholic cardiomyopathy	0.000	0.993	0.007
T39.1 4-Aminophenol derivatives	0.006	0.994	0.000
I42.7 Cardiomyopathy due to drugs and other external agents	0.000	0.994	0.006
I42.5 Other restrictive cardiomyopathy	0.000	0.994	0.006
I42.4 Endocardial fibroelastosis	0.000	0.994	0.006
I42.3 Endomyocardial (eosinophilic) disease	0.000	0.994	0.006
D03.7 Melanoma in situ of lower limb, including hip	0.006	0.994	0.000
D03 Melanoma in situ	0.006	0.994	0.000
R20.2 Paraesthesia of skin	0.000	0.995	0.005
M85.8 Other specified disorders of bone density and structure	0.005	0.995	0.000
I42.8 Other cardiomyopathies	0.000	0.995	0.005
D04 Carcinoma in situ of skin	0.005	0.995	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.005	0.995	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.005	0.995	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.005	0.995	0.000
D00-D09 In situ neoplasms	0.005	0.995	0.000
D04.2 Skin of ear and external auricular canal	0.004	0.995	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.004	0.995	0.000
D04.6 Skin of upper limb, including shoulder	0.004	0.995	0.000
D07.1 Vulva	0.004	0.995	0.000
D07.5 Prostate	0.004	0.996	0.000
D04.7 Skin of lower limb, including hip	0.004	0.996	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.004	0.996	0.000
D03.5 Melanoma in situ of trunk	0.004	0.996	0.000
D03.9 Melanoma in situ, unspecified	0.004	0.996	0.000
D03.8 Melanoma in situ of other sites	0.004	0.996	0.000
D03.4 Melanoma in situ of scalp and neck	0.004	0.996	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.004	0.996	0.000
D03.0 Melanoma in situ of lip	0.004	0.996	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.004	0.996	0.000
M85.88 Other specified disorders of bone density and structure (Other)	0.004	0.996	0.000
E78.5 Hyperlipidaemia, unspecified	0.004	0.996	0.000
M85.87 Other specified disorders of bone density and structure (Ankle and foot)	0.004	0.996	0.000
M85.86 Other specified disorders of bone density and structure (Lower leg)	0.004	0.996	0.000
M85.84 Other specified disorders of bone density and structure (Hand)	0.004	0.996	0.000
M85.83 Other specified disorders of bone density and structure (Forearm)	0.004	0.996	0.000
M85.82 Other specified disorders of bone density and structure (Upper arm)	0.004	0.996	0.000
M85.81 Other specified disorders of bone density and structure (Shoulder region)	0.004	0.996	0.000
M85.80 Other specified disorders of bone density and structure (Multiple sites)	0.004	0.996	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.004	0.996	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
D04.3 Skin of other and unspecified parts of face	0.004	0.996	0.000
I50.0 Congestive heart failure	0.000	0.996	0.004
N88.2 Stricture and stenosis of cervix uteri	0.004	0.996	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
D04.9 Skin, unspecified	0.004	0.996	0.000
D04.8 Skin of other sites	0.004	0.996	0.000
D04.1 Skin of eyelid, including canthus	0.004	0.996	0.000
D04.0 Skin of lip	0.004	0.996	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.004	0.996	0.000
T39.4 Antirheumatics, not elsewhere classified	0.004	0.996	0.000
T39.2 Pyrazolone derivatives	0.004	0.996	0.000
C34.3 Lower lobe, bronchus or lung	0.004	0.996	0.000
M85.85 Other specified disorders of bone density and structure (Pelvic region and thigh)	0.004	0.996	0.000
J34.8 Other specified disorders of nose and nasal sinuses	0.000	0.996	0.004
D07.6 Other and unspecified male genital organs	0.004	0.996	0.000
D07.4 Penis	0.004	0.996	0.000
D07.3 Other and unspecified female genital organs	0.004	0.996	0.000
D07.2 Vagina	0.004	0.996	0.000
D07.0 Endometrium	0.004	0.996	0.000
D04.5 Skin of trunk	0.004	0.996	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.004	0.996	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.004	0.996	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.004	0.996	0.000
I50.1 Left ventricular failure	0.000	0.996	0.004
O48 Prolonged pregnancy	0.000	0.996	0.004
D01.0 Colon	0.003	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.996	0.000
N88.8 Other specified noninflammatory disorders of cervix uteri	0.003	0.997	0.000
M85 Other disorders of bone density and structure	0.003	0.997	0.000
D01.3 Anus and anal canal	0.003	0.997	0.000
N35.9 Urethral stricture, unspecified	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
M24.16 Other articular cartilage disorders (Lower leg)	0.003	0.997	0.000
I50 Heart failure	0.000	0.997	0.003
N31.8 Other neuromuscular dysfunction of bladder	0.003	0.997	0.000
H44.0 Purulent endophthalmitis	0.003	0.997	0.000
D04.4 Skin of scalp and neck	0.003	0.997	0.000
D09 Carcinoma in situ of other and unspecified sites	0.003	0.997	0.000
D01.9 Digestive organ, unspecified	0.003	0.997	0.000
D01.7 Other specified digestive organs	0.003	0.997	0.000
D01.5 Liver, gallbladder and bile ducts	0.003	0.997	0.000
D01.4 Other and unspecified parts of intestine	0.003	0.997	0.000
D01.2 Rectum	0.003	0.997	0.000
D01.1 Rectosigmoid junction	0.003	0.997	0.000
I44.0 Atrioventricular block, first degree	0.003	0.997	0.000
E27 Other disorders of adrenal gland	0.003	0.997	0.000
E27.8 Other specified disorders of adrenal gland	0.003	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
E27.1 Primary adrenocortical insufficiency	0.003	0.997	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
T40.2 Other opioids	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
T44.0 Anticholinesterase agents	0.003	0.997	0.000
M85.9 Disorder of bone density and structure, unspecified	0.003	0.997	0.000
S00.0 Superficial injury of scalp	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
D06 Carcinoma in situ of cervix uteri	0.003	0.997	0.000
D36.7 Other specified sites	0.003	0.997	0.000
H44.2 Degenerative myopia	0.003	0.997	0.000
N88 Other noninflammatory disorders of cervix uteri	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
D02.0 Larynx	0.003	0.997	0.000
D02.4 Respiratory system, unspecified	0.003	0.997	0.000
D02.3 Other parts of respiratory system	0.003	0.997	0.000
D02.2 Bronchus and lung	0.003	0.997	0.000
D02.1 Trachea	0.003	0.997	0.000
T40.4 Other synthetic narcotics	0.003	0.997	0.000
D00.2 Stomach	0.003	0.997	0.000
D00.1 Oesophagus	0.003	0.997	0.000
D00.0 Lip, oral cavity and pharynx	0.003	0.997	0.000
E27.9 Disorder of adrenal gland, unspecified	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
H44 Disorders of globe	0.003	0.997	0.000
T39.0 Salicylates	0.003	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
M85.99 Disorder of bone density and structure, unspecified (Site unspecified)	0.003	0.997	0.000
M85.6 Other cyst of bone	0.003	0.997	0.000
D05 Carcinoma in situ of breast	0.003	0.997	0.000
M85.5 Aneurysmal bone cyst	0.003	0.997	0.000
M85.4 Solitary bone cyst	0.003	0.997	0.000
M85.3 Osteitis condensans	0.003	0.997	0.000
M85.2 Hyperostosis of skull	0.003	0.997	0.000
M85.1 Skeletal fluorosis	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.5 Cocaine	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
T40.1 Heroin	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
D36 Benign neoplasm of other and unspecified sites	0.003	0.997	0.000
C91.1 Chronic lymphocytic leukaemia	0.000	0.997	0.003
M85.0 Fibrous dysplasia (monostotic)	0.003	0.997	0.000
S00.1 Contusion of eyelid and periocular area	0.000	0.997	0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.997	0.000
D09.9 Carcinoma in situ, unspecified	0.002	0.997	0.000
D09.7 Carcinoma in situ of other specified sites	0.002	0.997	0.000
D09.3 Thyroid and other endocrine glands	0.002	0.997	0.000
D09.2 Eye	0.002	0.997	0.000
D09.1 Other and unspecified urinary organs	0.002	0.997	0.000
T46.1 Calcium-channel blockers	0.002	0.997	0.000
E27.5 Adrenomedullary hyperfunction	0.002	0.997	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.002	0.997	0.000
E27.0 Other adrenocortical overactivity	0.002	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.997	0.000
T46.7 Peripheral vasodilators	0.002	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.997	0.000
H44.8 Other disorders of globe	0.002	0.997	0.000
O04.9 Complete or unspecified, without complication	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
M85.98 Disorder of bone density and structure, unspecified (Other)	0.002	0.998	0.000
M85.97 Disorder of bone density and structure, unspecified (Ankle and foot)	0.002	0.998	0.000
M85.96 Disorder of bone density and structure, unspecified (Lower leg)	0.002	0.998	0.000
M85.95 Disorder of bone density and structure, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M85.94 Disorder of bone density and structure, unspecified (Hand)	0.002	0.998	0.000
M85.93 Disorder of bone density and structure, unspecified (Forearm)	0.002	0.998	0.000
M85.92 Disorder of bone density and structure, unspecified (Upper arm)	0.002	0.998	0.000
M85.91 Disorder of bone density and structure, unspecified (Shoulder region)	0.002	0.998	0.000
M85.90 Disorder of bone density and structure, unspecified (Multiple sites)	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T36.0 Penicillins	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T45.5 Anticoagulants	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
D06.7 Other parts of cervix	0.002	0.998	0.000
D06.1 Exocervix	0.002	0.998	0.000
D06.0 Endocervix	0.002	0.998	0.000
N88.4 Hypertrophic elongation of cervix uteri	0.002	0.998	0.000
N88.3 Incompetence of cervix uteri	0.002	0.998	0.000
N88.1 Old laceration of cervix uteri	0.002	0.998	0.000
N88.0 Leukoplakia of cervix uteri	0.002	0.998	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
K09.2 Other cysts of jaw	0.002	0.998	0.000
H44.1 Other endophthalmitis	0.002	0.998	0.000
L89.2 Stage III decubitus ulcer	0.002	0.998	0.000
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.002	0.998	0.000
E27.2 Addisonian crisis	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
S06.00 Concussion (without open intracranial wound)	0.000	0.998	0.002
M85.67 Other cyst of bone (Ankle and foot)	0.002	0.998	0.000
H44.9 Disorder of globe, unspecified	0.002	0.998	0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.002	0.998	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.002	0.998	0.000
H44.5 Degenerated conditions of globe	0.002	0.998	0.000
H44.4 Hypotony of eye	0.002	0.998	0.000
H44.3 Other degenerative disorders of globe	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.002	0.998	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
M85.69 Other cyst of bone (Site unspecified)	0.002	0.998	0.000
M85.68 Other cyst of bone (Other)	0.002	0.998	0.000
M85.66 Other cyst of bone (Lower leg)	0.002	0.998	0.000
M85.64 Other cyst of bone (Hand)	0.002	0.998	0.000
M85.63 Other cyst of bone (Forearm)	0.002	0.998	0.000
M85.62 Other cyst of bone (Upper arm)	0.002	0.998	0.000
M85.61 Other cyst of bone (Shoulder region)	0.002	0.998	0.000
M85.60 Other cyst of bone (Multiple sites)	0.002	0.998	0.000
M85.65 Other cyst of bone (Pelvic region and thigh)	0.002	0.998	0.000
D05.7 Other carcinoma in situ of breast	0.002	0.998	0.000
M85.19 Skeletal fluorosis (Site unspecified)	0.002	0.998	0.000
M85.18 Skeletal fluorosis (Other)	0.002	0.998	0.000
M85.17 Skeletal fluorosis (Ankle and foot)	0.002	0.998	0.000
M85.16 Skeletal fluorosis (Lower leg)	0.002	0.998	0.000
M85.15 Skeletal fluorosis (Pelvic region and thigh)	0.002	0.998	0.000
M85.14 Skeletal fluorosis (Hand)	0.002	0.998	0.000
M85.13 Skeletal fluorosis (Forearm)	0.002	0.998	0.000
M85.12 Skeletal fluorosis (Upper arm)	0.002	0.998	0.000
M85.11 Skeletal fluorosis (Shoulder region)	0.002	0.998	0.000
M85.10 Skeletal fluorosis (Multiple sites)	0.002	0.998	0.000
M85.29 Hyperostosis of skull-Site unspec	0.002	0.998	0.000
M85.28 Hyperostosis of skull-Other	0.002	0.998	0.000
M85.27 Hyperostosis of skull-Ankle/Foot	0.002	0.998	0.000
M85.26 Hyperostosis of skull-Lower Leg	0.002	0.998	0.000
M85.25 Hyperostosis of skull-Pelvic/Thigh	0.002	0.998	0.000
M85.24 Hyperostosis of skull-Hand	0.002	0.998	0.000
M85.23 Hyperostosis of skull-Forearm	0.002	0.998	0.000
M85.22 Hyperostosis of skull-Upper arm	0.002	0.998	0.000
M85.21 Hyperostosis of skull-Shldr region	0.002	0.998	0.000
M85.20 Hyperostosis of skull-Mult sites	0.002	0.998	0.000
M85.39 Osteitis condensans (Site unspecified)	0.002	0.998	0.000
M85.38 Osteitis condensans (Other)	0.002	0.998	0.000
M85.37 Osteitis condensans (Ankle and foot)	0.002	0.998	0.000
M85.36 Osteitis condensans (Lower leg)	0.002	0.998	0.000
M85.35 Osteitis condensans (Pelvic region and thigh)	0.002	0.998	0.000
M85.34 Osteitis condensans (Hand)	0.002	0.998	0.000
M85.33 Osteitis condensans (Forearm)	0.002	0.998	0.000
M85.32 Osteitis condensans (Upper arm)	0.002	0.998	0.000
M85.31 Osteitis condensans (Shoulder region)	0.002	0.998	0.000
M85.30 Osteitis condensans (Multiple sites)	0.002	0.998	0.000
M85.49 Solitary bone cyst (Site unspecified)	0.002	0.998	0.000
M85.48 Solitary bone cyst (Other)	0.002	0.998	0.000
M85.47 Solitary bone cyst (Ankle and foot)	0.002	0.998	0.000
M85.46 Solitary bone cyst (Lower leg)	0.002	0.998	0.000
M85.45 Solitary bone cyst (Pelvic region and thigh)	0.002	0.998	0.000
M85.44 Solitary bone cyst (Hand)	0.002	0.998	0.000
M85.43 Solitary bone cyst (Forearm)	0.002	0.998	0.000
M85.42 Solitary bone cyst (Upper arm)	0.002	0.998	0.000
M85.41 Solitary bone cyst (Shoulder region)	0.002	0.998	0.000
M85.40 Solitary bone cyst (Multiple sites)	0.002	0.998	0.000
M85.59 Aneurysmal bone cyst (Site unspecified)	0.002	0.998	0.000
M85.58 Aneurysmal bone cyst (Other)	0.002	0.998	0.000
M85.57 Aneurysmal bone cyst (Ankle and foot)	0.002	0.998	0.000
M85.56 Aneurysmal bone cyst (Lower leg)	0.002	0.998	0.000
M85.55 Aneurysmal bone cyst (Pelvic region and thigh)	0.002	0.998	0.000
M85.54 Aneurysmal bone cyst (Hand)	0.002	0.998	0.000
M85.53 Aneurysmal bone cyst (Forearm)	0.002	0.998	0.000
M85.52 Aneurysmal bone cyst (Upper arm)	0.002	0.998	0.000
M85.51 Aneurysmal bone cyst (Shoulder region)	0.002	0.998	0.000
M85.50 Aneurysmal bone cyst (Multiple sites)	0.002	0.998	0.000
I50.9 Heart failure, unspecified	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
D36.9 Benign neoplasm of unspecified site	0.002	0.998	0.000
D36.0 Lymph nodes	0.002	0.998	0.000
M85.09 Fibrous dysplasia (monostotic) (Site unspecified)	0.002	0.998	0.000
M85.08 Fibrous dysplasia (monostotic) (Other)	0.002	0.998	0.000
M85.07 Fibrous dysplasia (monostotic) (Ankle and foot)	0.002	0.998	0.000
M85.06 Fibrous dysplasia (monostotic) (Lower leg)	0.002	0.998	0.000
M85.05 Fibrous dysplasia (monostotic) (Pelvic region and thigh)	0.002	0.998	0.000
M85.04 Fibrous dysplasia (monostotic) (Hand)	0.002	0.998	0.000
M85.03 Fibrous dysplasia (monostotic) (Forearm)	0.002	0.998	0.000
M85.02 Fibrous dysplasia (monostotic) (Upper arm)	0.002	0.998	0.000
M85.01 Fibrous dysplasia (monostotic) (Shoulder region)	0.002	0.998	0.000
R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
I46.9 Cardiac arrest, unspecified	0.000	0.998	0.002
D09.0 Bladder	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
M85.00 Fibrous dysplasia (monostotic) (Multiple sites)	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
O32.1 Maternal care for breech presentation	0.000	0.998	0.002
H04.5 Stenosis and insufficiency of lachrymal passages	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.3 Barbiturates	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
T42.1 Iminostilbenes	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
M81.90 Osteoporosis, unspecified (Multiple sites)	0.002	0.998	0.000
E83.4 Disorders of magnesium metabolism	0.000	0.998	0.002
R20 Disturbances of skin sensation	0.000	0.998	0.002
D05.0 Lobular carcinoma in situ	0.002	0.998	0.000
E34.8 Other specified endocrine disorders	0.002	0.998	0.000
S00 Superficial injury of head	0.000	0.998	0.002
I45.6 Preexcitation syndrome	0.000	0.998	0.002
J33.8 Other polyp of sinus	0.000	0.998	0.002
E34 Other endocrine disorders	0.002	0.998	0.000
N35 Urethral stricture	0.002	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.000	0.998	0.002
E78.4 Other hyperlipidaemia	0.002	0.998	0.000
N35.8 Other urethral stricture	0.002	0.998	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.002	0.998	0.000
I46 Cardiac arrest	0.000	0.998	0.002
E34.9 Endocrine disorder, unspecified	0.002	0.998	0.000
S00.5 Superficial injury of lip and oral cavity	0.000	0.998	0.002
X49.9 Unspecified place	0.002	0.998	0.000
E20-E35 Disorders of other endocrine glands	0.002	0.998	0.000
I30-I52 Other forms of heart disease	0.000	0.998	0.002
I33.0 Acute and subacute infective endocarditis	0.000	0.998	0.002
O32.2 Maternal care for transverse and oblique lie	0.000	0.998	0.002
E29.1 Testicular hypofunction	0.002	0.998	0.000
E29 Testicular dysfunction	0.002	0.998	0.000
I33 Acute and subacute endocarditis	0.000	0.998	0.002
Q79.6 Ehlers-Danlos syndrome	0.002	0.998	0.000
E78.8 Other disorders of lipoprotein metabolism	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.998	0.000
E20 Hypoparathyroidism	0.002	0.998	0.000
I45.2 Bifascicular block	0.000	0.998	0.002
I45 Other conduction disorders	0.000	0.998	0.002
E20.9 Hypoparathyroidism, unspecified	0.002	0.998	0.000
I45.8 Other specified conduction disorders	0.000	0.998	0.002
R20.3 Hyperaesthesia	0.000	0.998	0.002
R20.1 Hypoaesthesia of skin	0.000	0.998	0.002
S00.2 Other superficial injuries of eyelid and periocular area	0.000	0.998	0.002
D06.9 Cervix, unspecified	0.002	0.998	0.000
S00.4 Superficial injury of ear	0.000	0.998	0.002
H21.1 Other vascular disorders of iris and ciliary body	0.002	0.998	0.000
R06.5 Mouth breathing	0.000	0.998	0.002
E78.9 Disorder of lipoprotein metabolism, unspecified	0.002	0.998	0.000
E78.1 Pure hyperglyceridaemia	0.002	0.998	0.000
H04.1 Other disorders of lachrymal gland	0.000	0.998	0.002
I73.0 Raynaud's syndrome	0.000	0.998	0.002
M24.07 Loose body in joint (Ankle and foot)	0.002	0.998	0.000
E34.5 Androgen resistance syndrome	0.001	0.998	0.000
E34.4 Constitutional tall stature	0.001	0.998	0.000
E34.3 Short stature, not elsewhere classified	0.001	0.998	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.001	0.998	0.000
E34.1 Other hypersecretion of intestinal hormones	0.001	0.998	0.000
I45.9 Conduction disorder, unspecified	0.000	0.998	0.002
N35.1 Postinfective urethral stricture, not elsewhere classified	0.002	0.998	0.000
N35.0 Posttraumatic urethral stricture	0.002	0.998	0.000
R25.1 Tremor, unspecified	0.000	0.998	0.002
S00.9 Superficial injury of head, part unspecified	0.000	0.998	0.002
E22 Hyperfunction of pituitary gland	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.998	0.000
E78.6 Lipoprotein deficiency	0.002	0.998	0.000
E78.3 Hyperchylomicronaemia	0.002	0.998	0.000
H21.0 Hyphaema	0.002	0.998	0.000
S00.3 Superficial injury of nose	0.000	0.998	0.002
S01.8 Open wound of other parts of head	0.000	0.998	0.002
Y89 Sequelae of other external causes	0.000	0.998	0.001
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.002	0.998	0.000
E22.1 Hyperprolactinaemia	0.002	0.998	0.000
E34.0 Carcinoid syndrome	0.001	0.998	0.000
I46.1 Sudden cardiac death, so described	0.000	0.998	0.001
R20.0 Anaesthesia of skin	0.000	0.998	0.001
I36 Nonrheumatic tricuspid valve disorders	0.000	0.998	0.002
S00.7 Multiple superficial injuries of head	0.000	0.998	0.001
E35 Disorders of endocrine glands in diseases classified elsewhere	0.001	0.998	0.000
E32 Diseases of thymus	0.001	0.998	0.000
E31 Polyglandular dysfunction	0.001	0.998	0.000
E30 Disorders of puberty, not elsewhere classified	0.001	0.998	0.000
E25 Adrenogenital disorders	0.001	0.998	0.000
I52 Other heart disorders in diseases classified elsewhere	0.000	0.998	0.001
I48 Atrial fibrillation and flutter	0.000	0.998	0.001
I43 Cardiomyopathy in diseases classified elsewhere	0.000	0.998	0.001
I41 Myocarditis in diseases classified elsewhere	0.000	0.998	0.001
I40 Acute myocarditis	0.000	0.998	0.001
I39 Endocarditis and heart valve disorders in diseases classified elsewhere	0.000	0.998	0.001
I32 Pericarditis in diseases classified elsewhere	0.000	0.998	0.001
E29.9 Testicular dysfunction, unspecified	0.001	0.998	0.000
E29.8 Other testicular dysfunction	0.001	0.998	0.000
E29.0 Testicular hyperfunction	0.001	0.998	0.000
I33.9 Acute endocarditis, unspecified	0.000	0.998	0.001
E78.2 Mixed hyperlipidaemia	0.001	0.998	0.000
O32 Maternal care for known or suspected malpresentation of foetus	0.000	0.998	0.002
E20.8 Other hypoparathyroidism	0.001	0.998	0.000
E20.1 Pseudohypoparathyroidism	0.001	0.998	0.000
E20.0 Idiopathic hypoparathyroidism	0.001	0.998	0.000
I45.0 Right fascicular block	0.000	0.998	0.001
T18.1 Foreign body in oesophagus	0.000	0.998	0.001
H21 Other disorders of iris and ciliary body	0.002	0.998	0.000
I47 Paroxysmal tachycardia	0.000	0.998	0.002
H21.5 Other adhesions and disruptions of iris and ciliary body	0.001	0.998	0.000
H04.3 Acute and unspecified inflammation of lachrymal passages	0.000	0.999	0.001
H50.1 Divergent concomitant strabismus	0.001	0.999	0.000
I36.1 Nonrheumatic tricuspid (valve) insufficiency	0.000	0.999	0.001
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.001	0.999	0.000
E28 Ovarian dysfunction	0.001	0.999	0.000
E26 Hyperaldosteronism	0.001	0.999	0.000
I31 Other diseases of pericardium	0.000	0.999	0.001
C53.9 Cervix uteri, unspecified	0.000	0.999	0.001
E22.9 Hyperfunction of pituitary gland, unspecified	0.001	0.999	0.000
E22.8 Other hyperfunction of pituitary gland	0.001	0.999	0.000
E24 Cushing's syndrome	0.001	0.999	0.000
I37 Pulmonary valve disorders	0.000	0.999	0.001
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.000	0.999	0.001
I36.9 Nonrheumatic tricuspid valve disorder, unspecified	0.000	0.999	0.001
I36.8 Other nonrheumatic tricuspid valve disorders	0.000	0.999	0.001
I36.2 Nonrheumatic tricuspid (valve) stenosis with insufficiency	0.000	0.999	0.001
I36.0 Nonrheumatic tricuspid (valve) stenosis	0.000	0.999	0.001
S06.0 Concussion	0.000	0.999	0.001
Y89.1 Sequelae of war operations	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations